DE69912422D1 - Methode zur behandlung von fruchtbarkeitsstörungen - Google Patents

Methode zur behandlung von fruchtbarkeitsstörungen

Info

Publication number
DE69912422D1
DE69912422D1 DE69912422T DE69912422T DE69912422D1 DE 69912422 D1 DE69912422 D1 DE 69912422D1 DE 69912422 T DE69912422 T DE 69912422T DE 69912422 T DE69912422 T DE 69912422T DE 69912422 D1 DE69912422 D1 DE 69912422D1
Authority
DE
Germany
Prior art keywords
fertility disorders
treating fertility
treating
antagonists
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69912422T
Other languages
English (en)
Other versions
DE69912422T2 (de
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Thomas Reissmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentaris IVF GmbH
Original Assignee
Zentaris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris AG filed Critical Zentaris AG
Publication of DE69912422D1 publication Critical patent/DE69912422D1/de
Application granted granted Critical
Publication of DE69912422T2 publication Critical patent/DE69912422T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69912422T 1998-04-23 1999-03-29 Methode zur behandlung von fruchtbarkeitsstörungen Expired - Lifetime DE69912422T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8274398P 1998-04-23 1998-04-23
US82743P 1998-04-23
PCT/EP1999/002133 WO1999055357A1 (en) 1998-04-23 1999-03-29 Method for the treatment of fertility disorders

Publications (2)

Publication Number Publication Date
DE69912422D1 true DE69912422D1 (de) 2003-12-04
DE69912422T2 DE69912422T2 (de) 2004-08-19

Family

ID=22173160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69912422T Expired - Lifetime DE69912422T2 (de) 1998-04-23 1999-03-29 Methode zur behandlung von fruchtbarkeitsstörungen

Country Status (24)

Country Link
US (1) US6319192B1 (de)
EP (1) EP1082129B1 (de)
JP (1) JP2002512975A (de)
KR (1) KR100632722B1 (de)
AT (1) ATE252910T1 (de)
AU (1) AU752415B2 (de)
BR (1) BR9909802A (de)
CA (1) CA2330131C (de)
CZ (1) CZ301912B6 (de)
DE (1) DE69912422T2 (de)
DK (1) DK1082129T3 (de)
ES (1) ES2207941T3 (de)
HU (1) HU228736B1 (de)
IL (1) IL139027A0 (de)
NO (1) NO326406B1 (de)
NZ (1) NZ507405A (de)
PL (1) PL195989B1 (de)
PT (1) PT1082129E (de)
RU (1) RU2221588C2 (de)
SI (1) SI1082129T1 (de)
SK (1) SK285192B6 (de)
TR (1) TR200003063T2 (de)
UA (1) UA66850C2 (de)
WO (1) WO1999055357A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (de) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
US8465412B2 (en) * 2001-01-12 2013-06-18 Michael Levy Uterine devices and method of use
US6623422B2 (en) * 2001-01-12 2003-09-23 Napoli, Llc Method and apparatus for assisted embryo implantation
WO2002067772A2 (en) * 2001-01-12 2002-09-06 Napoli, Llc. Intra-uterine devices and method of use
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
EP1908463B1 (de) * 2001-12-14 2011-09-28 Merck Serono SA Verfahren zur Herbeiführung einer Ovulation über einen Nicht-Polypeptid-CAMP-Spiegel-Modulator
US7033314B2 (en) * 2002-01-11 2006-04-25 Fidelitycorp Limited Endoscopic devices and method of use
US20030186892A1 (en) * 2002-03-28 2003-10-02 Rajneesh Taneja Enhancement of endogenous gonadotropin production
US6695766B2 (en) 2002-04-26 2004-02-24 Olympia Womens Health Magnetic embryo transfer
EP1364658A1 (de) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Verwendung von veränderlichen Verhältnissen an Gonadotrophinen in der kontrollierten Eierstockhyperstimulation
PL373991A1 (en) * 2002-06-07 2005-09-19 Ares Trading S.A. Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130137A (en) * 1989-08-09 1992-07-14 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
DE4305225A1 (de) 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0788799A3 (de) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
US5824548A (en) * 1996-05-29 1998-10-20 Wisconsin Alumni Research Foundation Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
US5961444A (en) * 1997-10-17 1999-10-05 Medworks Corporation In vitro fertilization procedure using direct vision

Also Published As

Publication number Publication date
HUP0101528A3 (en) 2001-12-28
HU228736B1 (en) 2013-05-28
CA2330131C (en) 2011-10-25
CZ20003766A3 (cs) 2001-08-15
CA2330131A1 (en) 1999-11-04
SK15302000A3 (sk) 2001-10-08
PL195989B1 (pl) 2007-11-30
JP2002512975A (ja) 2002-05-08
RU2221588C2 (ru) 2004-01-20
TR200003063T2 (tr) 2001-02-21
PL343609A1 (en) 2001-08-27
NO20005145D0 (no) 2000-10-13
DK1082129T3 (da) 2004-01-26
NO20005145L (no) 2000-10-13
AU752415B2 (en) 2002-09-19
UA66850C2 (uk) 2004-06-15
KR100632722B1 (ko) 2006-10-16
ATE252910T1 (de) 2003-11-15
NZ507405A (en) 2002-10-25
AU3702899A (en) 1999-11-16
SI1082129T1 (en) 2004-02-29
EP1082129A1 (de) 2001-03-14
WO1999055357A1 (en) 1999-11-04
US6319192B1 (en) 2001-11-20
HUP0101528A2 (hu) 2001-11-28
EP1082129B1 (de) 2003-10-29
ES2207941T3 (es) 2004-06-01
KR20010042873A (ko) 2001-05-25
BR9909802A (pt) 2000-12-26
SK285192B6 (sk) 2006-08-03
NO326406B1 (no) 2008-11-24
PT1082129E (pt) 2004-03-31
IL139027A0 (en) 2001-11-25
CZ301912B6 (cs) 2010-07-28
DE69912422T2 (de) 2004-08-19

Similar Documents

Publication Publication Date Title
DE69912422D1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
SE0100568D0 (sv) Compounds
ATE223902T1 (de) Chinolinderivate als gnrh antagonisten
YU7797A (sh) Kombinovana terapija za osteoporozu
ATE347353T1 (de) Verwendung von einem östrogen agonist/antagonist zur behandlung der weiblichen sexuellen störungen
FI963049A0 (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
CY1105370T1 (el) Μεθοδος θepαπειας των κλιμακτηριακων διαταραχων στις εμμηνοπαυσιακες και μετεμμηνοπαυσιακες γυναικες
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
EA200200132A1 (ru) СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ
ATE289293T1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
PL359726A1 (en) Animal device for collecting an animal's seminal fluid
SE0100566D0 (sv) Compounds
DK1342410T3 (da) Anvendelse af en galaninagonist til fremstilling af et medikament til forbedring af hukommelse og andre kognitive funktioner
ATE491464T1 (de) Lh zur verwendung der erhaltung einer oder mehreren schwangerschaften durch induktion der bildung des sekundären gelbkörpers.
PT1066304E (pt) Antagonistas macrolidos de lhrh
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
SE0101692D0 (sv) Compounds
MY131858A (en) Active ingredient combination for the pharmacological therapy of nicotine dependence
DE69220229D1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
DE60028682D1 (de) Wachstumhormone Inhibitoren Enthaltende pharmazeutische Zubereitungen oder ihre biologisch aktive Fragmente zur Behandlung von uterinen Myomas
EA200100801A1 (ru) Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения
UA31156A (uk) Спосіб лікування пневмоентеритів телят
UA36077A (uk) Спосіб моделювання пропранололового фіброзуючого альвеоліту

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AETERNA ZENTARIS GMBH, 60314 FRANKFURT, DE

8327 Change in the person/name/address of the patent owner

Owner name: ZENTARIS IVF GMBH, 60314 FRANKFURT, DE